Gallic acid attenuates thymic involution in the d-galactose induced accelerated aging mice
Introduction
Aging is associated with the changes in morphology and physiology of many organs and systems, including the immune system. Thymus is the primary central immune organ which provides a specialized environment for the development and maturation of T cells. The thymic epithelial cells (TECs) seem to be the most important for the thymic microenvironment (Anderson and Jenkinson, 2001). TECs can secrete many factors which are essential for the development of thymocytes. It has been reported that the thymus will degenerate with aging (Khalyavkin and Krut’ko, 2015) and the thymic microenvironment changes with age, including the structural disorder of the cortical thymic epithelial cells (cTECs) and medullary thymic epithelial cells (mTECs) (Aw et al., 2008). The thymus degenerates with aging and T-cell generation declines, which called the age-associated thymic involution (Haynes et al., 2000). The involution of thymus leads to a poor immune function of the body, thus increasing the susceptibility to many infectious diseases and the risk of autoimmune disease and cancer (Aspinall and Andrew, 2000a). The immunosenescence has been closely associated with thymic involution and is marked by age-related alterations of thymic microenvironment (Aw et al., 2009).
Gallic acid (GA, 3,4,5-Trihydroxybenzoic acid), as one of the dietary polyphenol, mainly exists in many plants including gallnut, tea, grapes, berries and other fruits as well as in wine. GA has the function of antioxidant and can scavenge on free radicals (Lu et al., 2006; Goszcz et al., 2017). It has diverse effects through several pharmacological and biochemical pathways, which makes it a valuable additive as nutritional supplements to prevent the cancer risks (Verma et al., 2013). GA has anti-tumorigenesis on various tumor types by inhibiting the proliferation and migration or inducing cytotoxicity and apoptosis of cancerous cells (You and Park, 2010; Liao et al., 2018; Moghtaderi et al., 2018). It can also induce endothelium-dependent contraction and strongly inhibited the endothelium-dependent relaxation (Sanae et al., 2003). However, whether GA has an effect on age-associated thymic involution remains unknown.
The forkhead box protein N1 (FoxN1) is one of the members of forkhead/winged helix transcription factor family, which is specifically expressed in the membrane of TECs and the skin. FoxN1 regulates the development and functional maturation of TECs (Romano et al., 2013). It has been reported that the expression of FoxN1 increased during the embryonic period while decreased in the postnatal thymus (Ortman et al., 2002). Deficiency in FoxN1, resulted in a cystic thymic rudiment and a hairless phenotype (Nehls et al., 1994). Previous studies have demonstrated that the up-regulation of FoxN1 expression reversed age-related thymic involution (Zook et al., 2011; Bredenkamp et al., 2014; Rode et al., 2015).
Some promising interventions to prevent or even reverse age-related thymic involution and restore immune function with aging are currently under investigation. The approaches of restoring thymic morphology and improving immune function with age-related thymic involution involved in various mechanisms. It has been reported that exogenous melatonin can reduce the involution of postnatal thymus (Tian et al., 2003). Overexpression of FoxN1 restored thymic function (Zook et al., 2011; Ruan et al., 2014). Whether GA can prevent the age-associated thymic involution via FoxN1 needs to be further investigated.
d-galactose (d-gal) has been commonly used to induce accelerated senescence in rodent models (Wei et al., 2005; Chogtu et al., 2018, Majdi2018). In order to explore whether GA has an effect on age-associated thymic involution and elucidate its underlying mechanism, in the present study, we examined the effects of GA in preventing the age related thymic involution and the alterations of FoxN1 expression in d-gal induced accelerated aging mice. These results suggested that GA mediates protective properties and has the potential of suppressing the thymic involution.
Section snippets
Animals and experimental design
ICR mice were purchased from the Tumor Hospital of Zhengzhou University. Mice were housed at a controlled temperature of 25 ± 1℃with a 12 -hs light/dark cycles. Mice had free access to food and water during the entire experiment. Animal care and research protocols were approved by the Medical Ethics Committee of Zhengzhou University and the study was carried out according to the guidelines for the Ethical Care of Experimental Animals (Ethics number: ZZUIRB 2018-017). Forty mice (two months of
GA improved the thymic shrinkage induced by d-galactose
In order to detect the thymic morphological changes of GA treatment groups, d-gal-induced aging group and normal control group, the body weight and the shape of thymus was measured before and after GA treatment (Fig. 2.A–B), and thymus indexes were calculated (Fig. 2.C). The weight and thymus indexes of the age-matched normal control group increased significantly after two months, and the GA treatment groups was increased significantly, while the d-gal-induced aging group increased not
Discussion
This study aimed to observe the effects of GA treatment on the anatomical morphology and cellular changes of the thymus in the d-gal induced aging mice. GA is one of the kind of natural phenolic compounds and found in a variety of natural plants such as gallnut, grape and tea plants. Various studies have shown that GA and its derivatives have antioxidant activity (Pal et al., 2010), and can scavenge free radicals that accumulated in the body. In addition, studies have proved that GA have the
Declaration of Competing Interest
The authors declare no conflict of interest.
Acknowledgments
This work was supported by the Youth Development Fund from School of Basic Medical Sciences, Zhengzhou University, China (No. JCYXY2016-YQ-05). Authors thank En-ming Chang (undergraduate student of School of Fine Arts, Zhengzhou University, China) for plotting the diagram of mice administration.
References (39)
- et al.
Thymic atrophy in the mouse is a soluble problem of the thymic environment
Vaccine
(2000) - et al.
Structure-activity relationship analysis of antioxidant ability and neuroprotective effect of gallic acid derivatives
Neurochem. Int.
(2006) - et al.
Gallic acid: molecular rival of cancer
Environ. Toxicol. Pharmacol.
(2013) - et al.
Gallic acid-induced lung cancer cell death is related to glutathione depletion as well as reactive oxygen species increase
Toxicol. In Vitro
(2010) - et al.
Gallic acid inhibits bladder cancer cell proliferation and migration via regulating fatty acid synthase (FAS)
J. Food Drug Anal.
(2018) - et al.
Overexpression of Foxn1 attenuates age-associated thymic involution and prevents the expansion of peripheral CD4 memory T cells
Blood
(2011) - et al.
Melatonin rejuvenates degenerated thymus and redresses peripheral immune functions in aged mice
Immunol. Lett.
(2003) - et al.
Behavioural study of the D-galactose induced aging model in C57BL/6J mice
Behav. Brain Res.
(2005) - et al.
Gallic acid prevents nonsteroidal anti-inflammatory drug-induced gastropathy in rat by blocking oxidative stress and apoptosis
Free Radic. Biol. Med.
(2010) - et al.
Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells
Toxicol. Sci.
(2006)
Derivatives of gallic acid induce apoptosis in tumoral cell lines and inhibit lymphocyte proliferation
Arch. Biochem. Biophys.
Phenotypic and immunohistological analyses of the human adult thymus: evidence for an active thymus during adult life
Cell. Immunol.
Immunity in the elderly: the role of the thymus
J. Comp. Pathol.
Subchronic toxicity study of gallic acid by oral administration in F344 rats
Food Chem. Toxicol.
Foxn1 is required to maintain the postnatal thymic microenvironment in a dosage-sensitive manner
Blood
Lymphostromal interactions in thymic development and function
Nat. Rev. Immunol.
Early Thymus Involution--Manifestation of an Aging Program or a Program of Development?
Biochemistry Mosc.
Architectural changes in the thymus of aging mice
Aging Cell
The human thymus during aging
Immunol. Res.
Cited by (15)
Metformin ameliorates thymus degeneration of mice by regulating mitochondrial function
2022, International ImmunopharmacologyCitation Excerpt :Finally, ECL chromogenic agent was added to expose the image, and the images were analyzed by Image J. The changes of T cell subsets in thymus were observed by flow cytometry according to the procedures reported previously [21]. Briefly, fresh thymus tissue was ground and thymocytes were isolated using a mesh sieve of 400, stained with APC-conjugated anti-mouse CD3, PE-conjugated anti‐mouse CD4, FITC-conjugated anti-mouse CD8 (Biolegend, San Diego, CA, USA), respectively, incubated in dark for 30 min and washed twice with PBS to remove the unbound antibodies.
Gallic acid for cancer therapy: Molecular mechanisms and boosting efficacy by nanoscopical delivery
2021, Food and Chemical ToxicologyCitation Excerpt :GA possesses pronounced pharmacological activities that are advantageous in disease therapy. The biological and therapeutic effects include anti-oxidant (Rakshit et al., 2020), anti-inflammatory (Nguyen-Ngo et al., 2020; Singla et al., 2020), anti-diabetic (Pereira et al., 2018), anti-apoptotic (Mehraban et al., 2019), hepatoprotective (Sousa et al., 2020), renoprotective (Nouri et al., 2020), neuroprotective (Diaz et al., 2020), anti-obesity (Tanaka et al., 2020b), and anti-aging (Guo et al., 2020). Consequently, GA is extensively applied in treatment of various disorders as discussed below.
Application of Chemometric Techniques In The Evaluation of Bioactive Compounds and Antioxidant Activity of Fruit From Brazilian Cerrado
2023, Journal of Food Measurement and CharacterizationTherapeutic Role of Phytophenol Gallic Acid for the Cure of COVID-19 Pathogenesis
2023, Endocrine, Metabolic and Immune Disorders - Drug TargetsGallic acid ameliorates thymic involution via activating Sox2 and Nanog
2022, Scandinavian Journal of Immunology
- 1
These authors contributed equally to this work.